Cargando…

Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission

OBJECTIVE: To investigate peripheral blood lymphocyte subpopulations, particularly helper T (Th) cells and cytokine expression before and after treatment in polymyositis (PM) and dermatomyositis (DM). PATIENTS AND METHODS: Ten patients with PM and 15 with DM were enrolled in this study. As a control...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimojima, Yasuhiro, Ishii, Wataru, Matsuda, Masayuki, Ikeda, Shu-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480870/
https://www.ncbi.nlm.nih.gov/pubmed/23115480
http://dx.doi.org/10.4137/CMAMD.S10272
_version_ 1782247641005948928
author Shimojima, Yasuhiro
Ishii, Wataru
Matsuda, Masayuki
Ikeda, Shu-ichi
author_facet Shimojima, Yasuhiro
Ishii, Wataru
Matsuda, Masayuki
Ikeda, Shu-ichi
author_sort Shimojima, Yasuhiro
collection PubMed
description OBJECTIVE: To investigate peripheral blood lymphocyte subpopulations, particularly helper T (Th) cells and cytokine expression before and after treatment in polymyositis (PM) and dermatomyositis (DM). PATIENTS AND METHODS: Ten patients with PM and 15 with DM were enrolled in this study. As a control we used 11 age-matched healthy subjects. We analyzed peripheral blood lymphocytes using flow cytometry. Serum cytokines were determined by enzyme-linked immunosorbent assay. RESULTS: Th2/Th1 and Th2/Th17 ratios were significantly higher in both PM and DM than in controls and this Th2-predominancy is marked in DM associated with interstitial pneumonia. IL-1β, IL-6 and TGF-β were significantly higher in both PM and DM and IL-4 showed a significant increase in DM when compared to controls. There was no significant correlation between either any lymphocyte subpopulations or serum cytokines and clinical severity markers such as the manual muscle strength test, serum creatine kinase, and the total CT score. Th2/Th17 in both PM and DM, as well as Th2/Th1 in the latter, significantly decreased after clinical remission compared with before treatment. CONCLUSIONS: Th2-predominancy as shown by the increase in Th2/Th1 and Th2/Th17 ratios may suggest active disease in PM/DM but does not reflect clinical severity.
format Online
Article
Text
id pubmed-3480870
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-34808702012-10-31 Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission Shimojima, Yasuhiro Ishii, Wataru Matsuda, Masayuki Ikeda, Shu-ichi Clin Med Insights Arthritis Musculoskelet Disord Original Research OBJECTIVE: To investigate peripheral blood lymphocyte subpopulations, particularly helper T (Th) cells and cytokine expression before and after treatment in polymyositis (PM) and dermatomyositis (DM). PATIENTS AND METHODS: Ten patients with PM and 15 with DM were enrolled in this study. As a control we used 11 age-matched healthy subjects. We analyzed peripheral blood lymphocytes using flow cytometry. Serum cytokines were determined by enzyme-linked immunosorbent assay. RESULTS: Th2/Th1 and Th2/Th17 ratios were significantly higher in both PM and DM than in controls and this Th2-predominancy is marked in DM associated with interstitial pneumonia. IL-1β, IL-6 and TGF-β were significantly higher in both PM and DM and IL-4 showed a significant increase in DM when compared to controls. There was no significant correlation between either any lymphocyte subpopulations or serum cytokines and clinical severity markers such as the manual muscle strength test, serum creatine kinase, and the total CT score. Th2/Th17 in both PM and DM, as well as Th2/Th1 in the latter, significantly decreased after clinical remission compared with before treatment. CONCLUSIONS: Th2-predominancy as shown by the increase in Th2/Th1 and Th2/Th17 ratios may suggest active disease in PM/DM but does not reflect clinical severity. Libertas Academica 2012-10-18 /pmc/articles/PMC3480870/ /pubmed/23115480 http://dx.doi.org/10.4137/CMAMD.S10272 Text en © 2012 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.
spellingShingle Original Research
Shimojima, Yasuhiro
Ishii, Wataru
Matsuda, Masayuki
Ikeda, Shu-ichi
Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
title Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
title_full Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
title_fullStr Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
title_full_unstemmed Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
title_short Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
title_sort phenotypes of peripheral blood lymphocytes and cytokine expression in polymyositis and dermatomyositis before treatment and after clinical remission
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480870/
https://www.ncbi.nlm.nih.gov/pubmed/23115480
http://dx.doi.org/10.4137/CMAMD.S10272
work_keys_str_mv AT shimojimayasuhiro phenotypesofperipheralbloodlymphocytesandcytokineexpressioninpolymyositisanddermatomyositisbeforetreatmentandafterclinicalremission
AT ishiiwataru phenotypesofperipheralbloodlymphocytesandcytokineexpressioninpolymyositisanddermatomyositisbeforetreatmentandafterclinicalremission
AT matsudamasayuki phenotypesofperipheralbloodlymphocytesandcytokineexpressioninpolymyositisanddermatomyositisbeforetreatmentandafterclinicalremission
AT ikedashuichi phenotypesofperipheralbloodlymphocytesandcytokineexpressioninpolymyositisanddermatomyositisbeforetreatmentandafterclinicalremission